Decreased Cytoplasmic Expression of ADAMTS14 Is Correlated with Reduced Survival Rates in Oral Squamous Cell Carcinoma Patients

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2020 Feb 28

PMID 32102222

Citations 10

Authors

Yueh-Min Lin

Chiao-Wen Lin

Jeng-Wei Lu

Kun-Tu Yeh

Shu-Hui Lin

Shun-Fa Yang

Affiliations

Soon will be listed here.

Abstract

A disintegrin and metalloproteinase with thrombospondin motif 14 (ADAMTS14) is a member of the zinc-dependent protease family that is implicated in the occurrence and progression of tumors. Oral cancer (OC) is a common cancer worldwide, but it is particularly prevalent in Taiwan. However, whether the expression of ADAMTS14 is correlated with the carcinogenesis and progression of oral squamous cell carcinoma (OSCC) has not yet been investigated. In this study, we used immunohistochemistry (IHC) to examine 250 OSCC specimens in order to identify correlations between the cytoplasmic expression of ADAMTS14 and (1) clinicopathological features of OSCC as well as (2) clinical outcomes of OSCC. Our results indicate that cytoplasmic expression of ADAMTS14 was lower in OSCC tissues than in normal tissues. In analyzing correlations between ADAMTS14 expression and clinicopathological features, we found that negative cytoplasmic expression of ADAMTS14 was significantly associated with higher frequencies of lymph node metastasis and more advanced AJCC stages (III/IV). Kaplan-Meier survival analysis revealed that negative cytoplasmic expression of ADAMTS14 was also associated with significantly worse OSCC survival. Univariate and multivariate analyses confirmed that cytoplasmic expression of ADAMTS14 was associated with lymph node metastasis, tumor stage, and tumor grade and also indicated that cytoplasmic ADAMTS14 expression may be an independent prognostic factor for OSCC. This is the first study to report that the cytoplasmic expression level of ADAMTS14 is associated with OSCC prognosis and tumor progression. Our data indicate that ADAMTS14 can serve as a prognostic marker and a potential therapeutic target for OSCC.

Citing Articles

The association between ADAMTS14/rs4747096 gene polymorphism and some risk factors and knee osteoarthritis.

Elshaarawy G, Salama I, Salama S, Abdelrahman A, Hassan M, Eissa E BMC Musculoskelet Disord. 2024; 25(1):867.

PMID: 39472918 PMC: 11523595. DOI: 10.1186/s12891-024-07943-8.

Increased NOTCH1 expression is associated with low survival in moderate/ poor differentiated human oral squamous cell carcinoma patients.

Mohammedsaleh Z, Moawadh M, Saleh F, Jalal M, Al-Otaibi A, Saeedi N J Cancer. 2023; 14(16):3023-3027.

PMID: 37859809 PMC: 10583578. DOI: 10.7150/jca.87128.

Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy.

Li Y, Cai H, Yang J, Xie X, Pei S, Wu Y Front Pharmacol. 2023; 14:1264345.

PMID: 37822877 PMC: 10562578. DOI: 10.3389/fphar.2023.1264345.

Prognostic and Clinical Implications of UNC13C expression in Hepatocellular Carcinoma Patients.

Kumar V, Lee C, Su T, Lin C, Mohammedsaleh Z, Yeh C Int J Med Sci. 2023; 20(9):1235-1239.

PMID: 37575271 PMC: 10416712. DOI: 10.7150/ijms.80488.

Cytoplasmic IGF2BP2 Protein Expression in Human Patients with Oral Squamous Cell Carcinoma: Prognostic and Clinical Implications.

Lin S, Lin C, Lu J, Yang W, Lin Y, Lu H Int J Med Sci. 2022; 19(7):1198-1204.

PMID: 35919812 PMC: 9339407. DOI: 10.7150/ijms.74751.

References

Colige A, Vandenberghe I, Thiry M, Lambert C, Van Beeumen J, Li S . Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem. 2001; 277(8):5756-66. DOI: 10.1074/jbc.M105601200. View

Liu L, Yang Z, Ni W, Xuan Y . ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma. Exp Mol Pathol. 2018; 104(2):134-139. DOI: 10.1016/j.yexmp.2018.02.004. View

Velmurugan B, Yeh K, Hsieh M, Yeh C, Lin C, Kao C . UNC13C Suppress Tumor Progression via Inhibiting EMT Pathway and Improves Survival in Oral Squamous Cell Carcinoma. Front Oncol. 2019; 9:728. PMC: 6694713. DOI: 10.3389/fonc.2019.00728. View

Zhou S, Yang W, Liu S, Li J, Zhang C, Zhu Y . Gene expression profiling of craniofacial fibrous dysplasia reveals ADAMTS2 overexpression as a potential marker. Int J Clin Exp Pathol. 2015; 7(12):8532-41. PMC: 4314047. View

Filou S, Korpetinou A, Kyriakopoulou D, Bounias D, Stavropoulos M, Ravazoula P . ADAMTS expression in colorectal cancer. PLoS One. 2015; 10(3):e0121209. PMC: 4364768. DOI: 10.1371/journal.pone.0121209. View

Salter R, Ashlin T, Kwan A, Ramji D . ADAMTS proteases: key roles in atherosclerosis?. J Mol Med (Berl). 2010; 88(12):1203-11. DOI: 10.1007/s00109-010-0654-x. View

Sheu M, Hsieh M, Chou Y, Wang P, Yeh C, Yang S . Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma. PLoS One. 2017; 12(2):e0172506. PMC: 5322915. DOI: 10.1371/journal.pone.0172506. View

Zhang L, Liu Y, Zheng P . Downregulation of ADAMTS18 May Serve as a Poor Prognostic Biomarker for Cervical Cancer Patients. Appl Immunohistochem Mol Morphol. 2017; 26(9):670-675. DOI: 10.1097/PAI.0000000000000496. View

Poonpet T, Honsawek S, Tammachote N, Kanitnate S, Tammachote R . ADAMTS14 gene polymorphism associated with knee osteoarthritis in Thai women. Genet Mol Res. 2013; 12(4):5301-9. DOI: 10.4238/2013.November.7.5. View

10.

Looijenga L, Stoop H, de Leeuw H, de Gouveia Brazao C, Gillis A, van Roozendaal K . POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003; 63(9):2244-50. View

11.

Lin S, Yeh C, Hsieh M, Lin Y, Chen M, Chen C . Low cytoplasmic casein kinase 1 epsilon expression predicts poor prognosis in patients with hepatocellular carcinoma. Tumour Biol. 2015; 37(3):3997-4005. DOI: 10.1007/s13277-015-4225-1. View

12.

Goertsches R, Comabella M, Navarro A, Perkal H, Montalban X . Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis. J Neuroimmunol. 2005; 164(1-2):140-7. DOI: 10.1016/j.jneuroim.2005.04.005. View

13.

Li L, Li C, Wang S, Wang Z, Jiang J, Wang W . Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype. Cancer Res. 2016; 76(7):1770-80. DOI: 10.1158/0008-5472.CAN-15-1625. View

14.

Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M . Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie. 2007; 90(2):369-79. DOI: 10.1016/j.biochi.2007.08.008. View

15.

Singh J, Zhang K, Wu J, Yang X . O-GlcNAc signaling in cancer metabolism and epigenetics. Cancer Lett. 2014; 356(2 Pt A):244-50. PMC: 4208982. DOI: 10.1016/j.canlet.2014.04.014. View

16.

Ho Y, Shih C, Yeh K, Shi B, Gong Z, Lin Y . Correlation between high expression levels of jumonji domain-containing 4 and short survival in cases of colon adenocarcinoma. Biochem Biophys Res Commun. 2018; 503(3):1442-1449. DOI: 10.1016/j.bbrc.2018.07.061. View

17.

Tao R, Li Q, Gao X, Ma L . Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma. Oncol Lett. 2018; 15(4):5879-5886. PMC: 5840531. DOI: 10.3892/ol.2018.8030. View

18.

Gottschall P, Howell M . ADAMTS expression and function in central nervous system injury and disorders. Matrix Biol. 2015; 44-46:70-6. PMC: 5068130. DOI: 10.1016/j.matbio.2015.01.014. View

19.

Bolz H, Ramirez A, von Brederlow B, Kubisch C . Characterization of ADAMTS14, a novel member of the ADAMTS metalloproteinase family. Biochim Biophys Acta. 2002; 1522(3):221-5. DOI: 10.1016/s0167-4781(01)00329-3. View

20.

Lin E, Liu C . The role of ADAMTSs in arthritis. Protein Cell. 2011; 1(1):33-47. PMC: 4418016. DOI: 10.1007/s13238-010-0002-5. View